v3.25.2
CONSOLILines of CreditDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Aug. 03, 2025
Jul. 28, 2024
Cash flows from operating activities:    
Net loss $ (231) $ (7,261)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 1,111 1,581
Non-cash inventory credit (67) (268)
Amortization 95 99
Stock-based compensation 156 176
Deferred income taxes 309 60
Gain sale of equipment (9) (4)
Non-cash restructuring (credit) expense (3,664) 1,643
Foreign currency exchange loss 122 45
Changes in assets and liabilities:    
Accounts receivable 3,482 (445)
Inventories (683) 3,458
Other current assets 212 (221)
Other assets 13 90
Accounts payable – trade (3,126) 884
Deferred revenue 63 105
Accrued restructuring (506) 640
Accrued expenses and deferred compensation 1,016 (478)
Income taxes 1,012 (310)
Net cash used in operating activities (695) (206)
Cash flows from investing activities:    
Capital expenditures (179) (501)
Proceeds from the sale of property, plant, and equipment 966 37
Proceeds from notes receivable 120 90
Proceeds from the sale of investments (rabbi trust) 237 229
Purchase of investments (rabbi trust) (158) (187)
Net cash provided by (used in) investing activities 986 (332)
Cash flows from financing activities:    
Procceds from line credit 5,886 4,010
Payments on lines of credit (552)  
Payment of debt issuance costs (120)  
Common stock surrendered for withholding taxes payable (60)  
Net cash provided by financing activities 5,154 4,010
Effect of foreign currency exchange rate changes on cash and cash equivalents 20 (12)
Increase in cash and cash equivalents 5,465 3,460
Cash and cash equivalents at beginning of period 5,629 10,012
Cash and cash equivalents at end of period $ 11,094 $ 13,472